259 related articles for article (PubMed ID: 31885094)
1. DC-AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet.
Li M; Tang H; Chan MD; Zhou X; Qian X
Med Phys; 2020 Mar; 47(3):1139-1150. PubMed ID: 31885094
[TBL] [Abstract][Full Text] [Related]
2. Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation.
Qian X; Tan H; Zhang J; Zhao W; Chan MD; Zhou X
Med Phys; 2016 Nov; 43(11):5889. PubMed ID: 27806598
[TBL] [Abstract][Full Text] [Related]
3. A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients.
Moassefi M; Faghani S; Conte GM; Kowalchuk RO; Vahdati S; Crompton DJ; Perez-Vega C; Cabreja RAD; Vora SA; Quiñones-Hinojosa A; Parney IF; Trifiletti DM; Erickson BJ
J Neurooncol; 2022 Sep; 159(2):447-455. PubMed ID: 35852738
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma.
Verma G; Chawla S; Mohan S; Wang S; Nasrallah M; Sheriff S; Desai A; Brem S; O'Rourke DM; Wolf RL; Maudsley AA; Poptani H
NMR Biomed; 2019 Feb; 32(2):e4042. PubMed ID: 30556932
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T
Sun YZ; Yan LF; Han Y; Nan HY; Xiao G; Tian Q; Pu WH; Li ZY; Wei XC; Wang W; Cui GB
BMC Med Imaging; 2021 Feb; 21(1):17. PubMed ID: 33535988
[TBL] [Abstract][Full Text] [Related]
6. High-content image generation for drug discovery using generative adversarial networks.
Hussain S; Anees A; Das A; Nguyen BP; Marzuki M; Lin S; Wright G; Singhal A
Neural Netw; 2020 Dec; 132():353-363. PubMed ID: 32977280
[TBL] [Abstract][Full Text] [Related]
7. Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma.
Akbari H; Rathore S; Bakas S; Nasrallah MP; Shukla G; Mamourian E; Rozycki M; Bagley SJ; Rudie JD; Flanders AE; Dicker AP; Desai AS; O'Rourke DM; Brem S; Lustig R; Mohan S; Wolf RL; Bilello M; Martinez-Lage M; Davatzikos C
Cancer; 2020 Jun; 126(11):2625-2636. PubMed ID: 32129893
[TBL] [Abstract][Full Text] [Related]
8. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
[TBL] [Abstract][Full Text] [Related]
9. Shape constrained fully convolutional DenseNet with adversarial training for multiorgan segmentation on head and neck CT and low-field MR images.
Tong N; Gou S; Yang S; Cao M; Sheng K
Med Phys; 2019 Jun; 46(6):2669-2682. PubMed ID: 31002188
[TBL] [Abstract][Full Text] [Related]
10. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma.
Elshafeey N; Kotrotsou A; Hassan A; Elshafei N; Hassan I; Ahmed S; Abrol S; Agarwal A; El Salek K; Bergamaschi S; Acharya J; Moron FE; Law M; Fuller GN; Huse JT; Zinn PO; Colen RR
Nat Commun; 2019 Jul; 10(1):3170. PubMed ID: 31320621
[TBL] [Abstract][Full Text] [Related]
11. Combining DC-GAN with ResNet for blood cell image classification.
Ma L; Shuai R; Ran X; Liu W; Ye C
Med Biol Eng Comput; 2020 Jun; 58(6):1251-1264. PubMed ID: 32221797
[TBL] [Abstract][Full Text] [Related]
12. Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM.
Rowe LS; Butman JA; Mackey M; Shih JH; Cooley-Zgela T; Ning H; Gilbert MR; Smart DK; Camphausen K; Krauze AV
J Neurooncol; 2018 Aug; 139(1):145-152. PubMed ID: 29767308
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
Kertels O; Mihovilovic MI; Linsenmann T; Kessler AF; Tran-Gia J; Kircher M; Brumberg J; Monoranu CM; Samnick S; Ernestus RI; Löhr M; Meyer PT; Lapa C
Clin Nucl Med; 2019 Sep; 44(9):695-701. PubMed ID: 31274552
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
15. Functional network connectivity (FNC)-based generative adversarial network (GAN) and its applications in classification of mental disorders.
Zhao J; Huang J; Zhi D; Yan W; Ma X; Yang X; Li X; Ke Q; Jiang T; Calhoun VD; Sui J
J Neurosci Methods; 2020 Jul; 341():108756. PubMed ID: 32380227
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Glioblastoma Multiforme Progression via Interpretable Structure-Constrained Graph Neural Networks.
Song X; Li J; Qian X
IEEE Trans Med Imaging; 2023 Feb; 42(2):380-390. PubMed ID: 36018877
[TBL] [Abstract][Full Text] [Related]
17. Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
Kebir S; Fimmers R; Galldiks N; Schäfer N; Mack F; Schaub C; Stuplich M; Niessen M; Tzaridis T; Simon M; Stoffels G; Langen KJ; Scheffler B; Glas M; Herrlinger U
Clin Cancer Res; 2016 May; 22(9):2190-6. PubMed ID: 26673798
[TBL] [Abstract][Full Text] [Related]
18. Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study.
Qian X; Tan H; Zhang J; Liu K; Yang T; Wang M; Debinskie W; Zhao W; Chan MD; Zhou X
Oncotarget; 2016 Aug; 7(34):55377-55394. PubMed ID: 27421136
[TBL] [Abstract][Full Text] [Related]
19. Pseudo progression identification of glioblastoma with dictionary learning.
Zhang J; Yu H; Qian X; Liu K; Tan H; Yang T; Wang M; Li KC; Chan MD; Debinski W; Paulsson A; Wang G; Zhou X
Comput Biol Med; 2016 Jun; 73():94-101. PubMed ID: 27100835
[TBL] [Abstract][Full Text] [Related]
20. Synthetic CT reconstruction using a deep spatial pyramid convolutional framework for MR-only breast radiotherapy.
Olberg S; Zhang H; Kennedy WR; Chun J; Rodriguez V; Zoberi I; Thomas MA; Kim JS; Mutic S; Green OL; Park JC
Med Phys; 2019 Sep; 46(9):4135-4147. PubMed ID: 31309586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
